Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | SCN10A | Q9Y5Y9 | 6/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MLKL | Q8NB16 | 2/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2757079 | 0.86 | KDM4E (0.59) | CYP1A2ALDH1A1HPGDHTTUSP2 | |
| SCHEMBL5111363 | 0.82 | TAAR1 (0.47) | CYP1A2ALDH1A1HPGDHTTUSP2 | |
| SCHEMBL4154842 | 0.81 | CSNK2A1 (0.45) | CYP1A2ALDH1A1HTTKDM4ELMNA | |
| SCHEMBL5101171 | 0.81 | CSNK2A1 (0.45) | CYP1A2ALDH1A1HTTKDM4ELMNA | |
| SCHEMBL580393 | 0.81 | LMNA (0.42) | CYP1A2ALDH1A1HPGDHTTKDM4E | |
| SCHEMBL6471271 | 0.81 | ALPL (0.49) | CYP1A2ALDH1A1KDM4ELMNAHSD17B10 | |
| SCHEMBL8071559 | 0.81 | ALPL (0.49) | CYP1A2ALDH1A1KDM4ELMNAHSD17B10 | |
| SCHEMBL1479636 | 0.81 | LMNA (0.42) | CYP1A2ALDH1A1HPGDHTTKDM4E | |
| SCHEMBL5110077 | 0.81 | KDM4E (0.42) | CYP1A2ALDH1A1HPGDHTTUSP2 | |
| SCHEMBL8071556 | 0.81 | ALPL (0.49) | CYP1A2ALDH1A1KDM4ELMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080207683-A1 | BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. | 2008-08-28 | — | — | US | claimed |
| WO-2008100622-A2 | BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. (US) | 2008-08-21 | — | — | WO | claimed |
| US-20260138071-A1 | SULFIDE GAS REMOVAL PROCESS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-05-21 | — | — | US | disclosed |
| US-20260014197-A1 | DRUG DELIVERY SYSTEM | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260014517-A1 | HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260014514-A1 | METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260008009-A1 | PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-08 | — | — | US | disclosed |
| US-20260002088-A1 | PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-01 | — | — | US | disclosed |
| US-20250381514-A1 | METHOD FOR REMOVING HYDROGEN SULFIDE FROM SOUR GAS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-12-18 | — | — | US | disclosed |
| US-12459862-B2 | Cement paste composition | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-04 | — | — | US | disclosed |
| US-12427499-B2 | Process for removing hydrogen sulfide from sour gases | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-09-30 | — | — | US | disclosed |
| US-20230404932-A1 | METHOD FOR TREATING BLASTOCYSTIS INFECTION | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-12-21 | — | — | US | disclosed |
| US-20230404931-A1 | METHOD FOR FORMING A NANOMEDICINAL COMPOSITION | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-12-21 | — | — | US | disclosed |
| US-20230404930-A1 | METAL ORGANIC FRAMEWORK/POROUS SILICATE AND/OR ALUMINOSILICATE NANOCARRIER FOR BLASTOCYSTOSIS TREATMENT | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-12-21 | — | — | US | disclosed |
| US-11826477-B1 | Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-11-28 | — | — | US | disclosed |
| US-11746278-B1 | Method of removing sulfide-containing scale | KING FAHD UNIVERSITY OF PETROLEUM AND (SA) | 2023-09-05 | — | — | US | disclosed |
| US-11708517-B1 | Hydrogen sulfide mitigating drilling fluid and method of drilling subterranean geological formation | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-07-25 | — | — | US | disclosed |
| US-20200269194-A1 | POROUS MEMBRANE CONTAINING METAL-ORGANIC FRAMEWORKS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-08-27 | — | — | US | disclosed |
| US-20080207683-A1 | BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. | 2008-08-28 | — | — | US | disclosed |
| WO-2008100622-A2 | BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. (US) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008009-A1 | PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION | HMOX2, HMOX1, SCO2 | CYP1A2 1297/4885ALDH1A1 3365/4885HPGD 2831/4885 |
| US-20260014517-A1 | HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION | TST, SOD1, SAMM50 | CYP1A2 3591/4885ALDH1A1 3428/4885HPGD 2825/4885 |
| US-11826477-B1 | Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment | CAT, GPX1, SLC39A11 | CYP1A2 1780/4885ALDH1A1 1463/4885HPGD 4114/4885 |
| US-20230404930-A1 | METAL ORGANIC FRAMEWORK/POROUS SILICATE AND/OR ALUMINOSILICATE NANOCARRIER FOR BLASTOCYSTOSIS TREATMENT | CAT, GPX1, SLC39A11 | CYP1A2 1780/4885ALDH1A1 1463/4885HPGD 4114/4885 |
| US-20230404932-A1 | METHOD FOR TREATING BLASTOCYSTIS INFECTION | CAT, GPX1, GPX4 | CYP1A2 969/4885ALDH1A1 1263/4885HPGD 3657/4885 |
| US-20260002088-A1 | PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION | SAMM50, SOD1, HNRNPH3 | CYP1A2 1844/4885ALDH1A1 3149/4885HPGD 2333/4885 |
| US-20260138071-A1 | SULFIDE GAS REMOVAL PROCESS | SAMM50, SRSF1, GTF2F1 | CYP1A2 3087/4885ALDH1A1 4587/4885HPGD 2762/4885 |
| US-20260014514-A1 | METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR | SOD1, MAFG, HMOX2 | CYP1A2 3587/4885ALDH1A1 4774/4885HPGD 1662/4885 |
| US-20230404931-A1 | METHOD FOR FORMING A NANOMEDICINAL COMPOSITION | GPX1, GPX4, CAT | CYP1A2 1324/4885ALDH1A1 1362/4885HPGD 2867/4885 |
| US-20260014197-A1 | DRUG DELIVERY SYSTEM | IPO8, SLC39A11, SLC2A8 | CYP1A2 2705/4885ALDH1A1 3703/4885HPGD 4499/4885 |
| US-20080207683-A1 | BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | CTSS, CTSK, CTSZ | CYP1A2 2244/4885ALDH1A1 4560/4885HPGD 2447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.